The overall goal of this Program Project Grant is to elucidate basic mechanisms that are responsible for regulation of the cerebral circulation. The focus of the research is on cerebral circulation, cerebral endothelium and the blood-brain barrier, and the choroid plexus. The program can be characterized by four themes: First, responses of cerebral blood vessels to neurohumoral stimuli will be examined. Studies are proposed to examine effects of peripheral and central neural pathways on cerebral blood flow, and to study responses to vasoactive amines and hormones in vitro and in vivo. Second, mediators of injury and mechanisms of protection will be examined. Effects of eicosanoids will be studied in vitro and in vivo, in cerebral vessels and in choroid plexus. Studies also are proposed to examine the role of medium-chain fatty acids, oxygen radicals, and inflammatory mediators on cerebral endothelium and blood vessels. Third, induction of properties of cerebral blood vessels will be studied. Experiments are proposed to examine induction of barrier-properties in endothelium by astrocytes and induction of cerebral vascular hypertrophy by sympathetic nerves. Fourth, cerebral vascular effects of chronic hypertension will be studied. Experiments are proposed to examine hemodynamic consequences of vascular hypertrophy, intrinsic abnormalities of the blood-brain barrier in chronic hypertension, and mechanism by which K+ protects cerebral vessels. The program consists of five research projects: Studies of the Blood-Brain Barrier In Vitro, Leukotrienes and Medium-Chain Fatty Acids in the Central Nervous System, Central Neural Regulation of Cerebral Blood Flow, Neurohumoral Regulation of Cerebral Circulation, and Effects of Hypertension on Cerebral Circulation. These projects are supported by 3 core facilities: Administrative/Biostatistics, Morphology, and Hypertensive Animal Core.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
1P01NS024621-01
Application #
3100150
Study Section
(SRC)
Project Start
1987-04-01
Project End
1992-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Ketsawatsomkron, Pimonrat; Keen, Henry L; Davis, Deborah R et al. (2016) Protective Role for Tissue Inhibitor of Metalloproteinase-4, a Novel Peroxisome Proliferator-Activated Receptor-? Target Gene, in Smooth Muscle in Deoxycorticosterone Acetate-Salt Hypertension. Hypertension 67:214-22
Dayal, Sanjana; Gu, Sean X; Hutchins, Ryan D et al. (2015) Deficiency of superoxide dismutase impairs protein C activation and enhances susceptibility to experimental thrombosis. Arterioscler Thromb Vasc Biol 35:1798-804
Rodionov, Roman N; Jarzebska, Natalia; Weiss, Norbert et al. (2014) AGXT2: a promiscuous aminotransferase. Trends Pharmacol Sci 35:575-82
De Silva, T Michael; Modrick, Mary L; Ketsawatsomkron, Pimonrat et al. (2014) Role of peroxisome proliferator-activated receptor-? in vascular muscle in the cerebral circulation. Hypertension 64:1088-93
Chrissobolis, Sophocles; Drummond, Grant R; Faraci, Frank M et al. (2014) Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation. J Hypertens 32:1815-21
Khoo, Nicholas K H; Hebbar, Sachin; Zhao, Weiling et al. (2013) Differential activation of catalase expression and activity by PPAR agonists: implications for astrocyte protection in anti-glioma therapy. Redox Biol 1:70-9
Weiss, Robert M; Lund, Donald D; Chu, Yi et al. (2013) Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice. PLoS One 8:e65201
Johnson, Andrew W; Kinzenbaw, Dale A; Modrick, Mary L et al. (2013) Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertension. Hypertension 61:437-42
Chu, Yi; Lund, Donald D; Weiss, Robert M et al. (2013) Pioglitazone attenuates valvular calcification induced by hypercholesterolemia. Arterioscler Thromb Vasc Biol 33:523-32
Klykov, Corinne M; Lentz, Steven R (2013) Trends in clinical laboratory homocysteine testing from 1997 to 2010: the impact of evidence on clinical practice at a single institution. Clin Chem Lab Med 51:671-5

Showing the most recent 10 out of 432 publications